Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian I Rini

Showing results (61-70 of 401) with videos related to

Pageof 41
Sort By:
Cancers|October 27, 2022
Treatment of Refractory Metastatic Renal Cell CarcinomaJoseph A Vento, Brian I Rini
Lancet (London, England)|June 8, 2023
Sequencing checkpoint inhibitor therapy in renal cell carcinomaKathryn E Beckermann, Brian I Rini
World Journal of Urology|February 26, 2013
The ineligible patient: how to treat patients not included in clinical studiesFrances J Mao, Brian I Rini
Expert Review of Anticancer Therapy|May 5, 2016
The safety and efficacy of nivolumab for the treatment of advanced renal cell carcinomaMoshe C Ornstein, Brian I Rini
Cancers|September 23, 2020
Predicting Response to Immunotherapy in Metastatic Renal Cell CarcinomaMatthew D Tucker, Brian I Rini
Expert Review of Anticancer Therapy|June 7, 2008
Molecular genetics of hereditary renal cancer: new genes and diagnostic and therapeutic opportunitiesDonna E Hansel, Brian I Rini
Nature Reviews. Clinical Oncology|June 23, 2023
A triple dose of optimism: an initial foray into triplet therapy in metastatic renal cell carcinomaKathryn E Beckermann, Brian I Rini
Oncology (Williston Park, N.Y.)|May 14, 2008
Targeted therapy for metastatic renal cell carcinoma: a home run or a work in progress?Brian I Rini, Ronald M Bukowski
Current Treatment Options in Oncology|August 27, 2002
Hormone-refractory Prostate CancerBrian I Rini, Eric J Small
The Journal of Urology|May 19, 2007
The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapyBrian I Rini, Steven C Campbell
Pageof 41

Showing results (61-70 of 401) with videos related to

Sort By:
Pageof 41
Cancers|October 27, 2022
Treatment of Refractory Metastatic Renal Cell CarcinomaJoseph A Vento, Brian I Rini
Lancet (London, England)|June 8, 2023
Sequencing checkpoint inhibitor therapy in renal cell carcinomaKathryn E Beckermann, Brian I Rini
World Journal of Urology|February 26, 2013
The ineligible patient: how to treat patients not included in clinical studiesFrances J Mao, Brian I Rini
Expert Review of Anticancer Therapy|May 5, 2016
The safety and efficacy of nivolumab for the treatment of advanced renal cell carcinomaMoshe C Ornstein, Brian I Rini
Cancers|September 23, 2020
Predicting Response to Immunotherapy in Metastatic Renal Cell CarcinomaMatthew D Tucker, Brian I Rini
Expert Review of Anticancer Therapy|June 7, 2008
Molecular genetics of hereditary renal cancer: new genes and diagnostic and therapeutic opportunitiesDonna E Hansel, Brian I Rini
Nature Reviews. Clinical Oncology|June 23, 2023
A triple dose of optimism: an initial foray into triplet therapy in metastatic renal cell carcinomaKathryn E Beckermann, Brian I Rini
Oncology (Williston Park, N.Y.)|May 14, 2008
Targeted therapy for metastatic renal cell carcinoma: a home run or a work in progress?Brian I Rini, Ronald M Bukowski
Current Treatment Options in Oncology|August 27, 2002
Hormone-refractory Prostate CancerBrian I Rini, Eric J Small
The Journal of Urology|May 19, 2007
The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapyBrian I Rini, Steven C Campbell
Pageof 41